Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vandetanib in Advanced Thyroid Carcinoma
NCT00537095Phase 2Completed
- Sponsor
- Sanofi
- Start
- Sep 2007
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of vandetanib in Papillary Thyroid Carcinoma (PTC), follicular thyroid carcinoma (FTC), sponsored by Sanofi. Started Sep 2007; status: completed.
02
Drugs
vandetanib
03
Conditions
Papillary Thyroid Carcinoma (PTC)follicular thyroid carcinoma (FTC)
Beyond the preview
Go deeper on NCT00537095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00537095.